BioFire Defense Chief Medical Officer Dr. Chuck Cooper discusses ongoing efforts to support frontline outbreak response and scale-up test manufacturing.
Public source
Publisher name
Public post
In the fight against expanding health threats, fast diagnostic clarity remains one of our most critical tools to help contain the spread. Dr. Chuck Cooper, Chief Medical…
Company
BioFire Defense
Aligning Readiness: Innovate, Shield, Excel
- Industry
- Biotechnology
- Company size
- 51–200 employees
About BioFire Defense
BioFire Defense is a proud member of the bioMérieux family — we play a critical role in helping to make the world a healthier place. We are on a mission to Align Readiness across government agencies protecting us from biothreats and emerging infectious diseases. We execute our mission focused on purposeful innovation, advancing global health security, and delivering uncompressing quality to our partners in the U.S. government, military, and public health agencies. BioFire Defense empowers government agencies, first responders, and healthcare professionals with actionable biothreat detection and diagnostic intelligence — protecting health and ensuring readiness against evolving threats.
See moreLatest activity
Latest activity from BioFire Defense
3 signals
Partnerships
BioFire Defense is the sole supplier of the BIOFIRE portfolio of multiplex PCR diagnostic tests to the United States Department of War and other U.S. Government Agencies.
Research & Knowledge
BioFire Defense Vice President Matt Scullion shares how syndromic testing strengthens global surveillance networks to catch emerging pathogens early and prevent large-scale outbreaks.
Discover more
Similar signals
Similar public activity from other companies.
Presence & Recognition
bioMérieux
bioMérieux shared a brief update about the ongoing Ebola outbreak in the Democratic Republic of Congo with ADLM.
Presence & Recognition
Emergent BioSolutions
Emergent BioSolutions featured Dr. Paul Keim, Dr. Daniel Lucey, and Dr. Asha M. George in the newest episode of Countermeasures discussing the anthrax attacks and their legacy in biodefense, health preparedness, and national security.
Presence & Recognition
MeMed
MeMed hosted an ADLM podcast featuring Co-Founder and CEO Eran Eden discussing the science and vision behind MeMedBV and its potential to support clinical decisions, advance antibiotic stewardship, and improve patient management with suspected sepsis.
Presence & Recognition
Cepheid
Cepheid hosted an Asian Pacific Society of Respirology (APSR) webinar on demand featuring Dr. Cristina Russo and Dr. Patrick Harris to explore the evolving respiratory landscape, optimizing diagnostic strategies, and achieving clinical and economic efficiencies across respiratory care settings.
Presence & Recognition
Diasorin